Background: The aim of the study was to analyze whether or not a short
-term test is able to detect drug resistance of tumors caused by vario
us resistance mechanisms. Materials and Methods: The drug resistance o
f 94 human non-small-cell lung carcinomas was measured using an in vit
ro short-term test. Its basic feature is measurement of changes in the
incorporation of radioactive nucleic acid precursors into cell suspen
sions made from fresh tumor biopsies after addition of doxorubicin. Th
e expression of P-glycoprotein, glutathione S-transferase pi, topoisom
erase II, catalase, thymidylate synthase, and metallothionein was asse
ssed immunohistochemically using alcohol-fixed paraffin-embedded secti
ons. Results: Significant correlations were found between the results
of the short-term test and the increased expression of P-glycoprotein,
glutathione S-transferase pi, thymidylate synthase, and metallothione
in. In 44% of the doxorubicin-resistant tumors all four resistance-rel
ated proteins were detected; in 85% of the doxorubicin-resistant tumor
s more than one of these proteins were detected. The probability of de
tecting resistance by an in vitro short-term test increases with the n
umber of resistance-related proteins in the tumor. Conclusion: The in
vitro short-term test may thus help to detect different resistance mec
hanisms.